The company recently expanded its pipeline by acquiring DMX-200 for kidney disease.
Searching for biotech stocks under $10 reveals several companies with strong analyst backing and significant upcoming catalysts. As of late 2025 and early 2026, the following stocks are frequently highlighted by financial experts for their growth potential: Top Rated Biotech Stocks Under $10 : best biotech stocks to buy under $10
While reporting a net loss in mid-2025, it reaffirmed revenue growth guidance of 15–22%. : Trading around $8.05 as of April 2026. The company recently expanded its pipeline by acquiring